top of page
MS.jpg

IN THE STATES

MISSISSIPPI

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Mississippi in 2022.

MS.png

Economic
Output

$3.4B

Direct Jobs Supported by the Industry

2,477

Total Jobs Supported

11,454

State Total Vendor Relationships

59

State Total Vendor Spending

$27,727,749

Clinical
Trials

190

Investments at Clinical Trial Sites

$51.9M

Clinical Trial Participants

2,798

Total Economic Impact of Clinical Trial Sites

$118.8M

bottom of page